Tuesday, May 29, 2018 - 18:56

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on May 29, 2018, in Marseille, France. Except resolution 33, relating to double voting rights, all resolutions were adopted.

A total of 21,676,115 votes was cast out of a total of 57,581,525 shares with voting rights, representing a quorum of 37.644%.

Details of the votes as well as the 2017 Reference Document are available on the Company’s website, in the Annual General Meeting 2018 section.

PR in English69.42 KB
CP en français91.75 KB